Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Retinal Disorder Treatment Market Transformation: Key Market Size Changes in Recent Years
There has been a considerable expansion in the market size for retinal disorder treatment in recent times. The market is predicted to rise from $12.59 billion in 2024 to $13.82 billion in 2025, marking a compound annual growth rate (CAGR) of 9.7%. The growth seen in the past owes itself to the introduction of anti-VEGF therapies, a growing elderly population, a rise in retinal disorder cases, enhancement in diagnostic tools allowing early detection, elevating awareness and screening programs, and increased accessibility to healthcare services.
The market for treating retinal disorders is anticipated to witness robust growth in the coming years, projected to reach $19.62 billion in 2029 with a compound annual growth rate (CAGR) of 9.2%. The predicted growth during this period is attributed to factors such as patient-focused approaches in retinal healthcare, a rise in global healthcare spending, increased emphasis on combination therapies for retinal disorders, the emergence of home-based monitoring for retinal disorders, growing acceptance of implantable devices for retinal therapy, and the use of regenerative medicine in treating the retina. Key trends predicted over this forecast period include improvements in ophthalmic imaging technologies, the progress of minimally invasive surgical methods, the use of artificial intelligence in diagnostics, advances in drug delivery technologies, the integration of virtual reality in retinal rehabilitation, partnerships between research institutions and pharmaceutical companies, and the advancement of gene therapies for inherited retinal conditions.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What’s Behind the Consistent Growth of the Retinal Disorder Treatment Industry?
The retinal disorder treatment market is anticipated to expand due to the increasing prevalence of retinal illnesses. Medical conditions affecting the retina and the light-responsive tissue located at the back of the eye are referred to as retinal diseases, which may lead to loss of vision or significant visual impairment. The symptoms of retinal disorders can be managed and minimized with treatments including laser therapy, vitrectomy, and retinal implants. For example, in January 2023, the UK-based International Agency for the Prevention of Blindness predicts that age-related macular degeneration (AMD) will account for approximately 5% of total blindness globally. Furthermore, AMD conditions are projected to affect 288 million individuals by 2040. As a result, the escalating occurrence of retinal disorders is fueling the growth of the retinal disorder treatment market.
Top Revenue-Generating Segments in the Retinal Disorder Treatment Market
The retinal disorder treatment market covered in this report is segmented –
1) By Type: Macular Degeneration, Diabetic Retinopathy, Other Types
2) By Dosage Form: Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
Subsegments:
1) By Macular Degeneration: Dry Macular Degeneration, Wet Macular Degeneration
2) By Diabetic Retinopathy: Non-Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy
3) By Other Types: Retinal Detachment, Retinitis Pigmentosa, Uveitis, Other Retinal Disorders
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
What Technological Trends Are Set to Revolutionize the Retinal Disorder Treatment Market?
Novel product development is a trending strategy being adopted in the retinal disorder treatment market to maintain market dominance.
Major players such as Switzerland’s F. Hoffmann-La Roche AG are rolling out innovative treatments. As an example, in January 2022, the company received authorization from the U.S. Food and Drug Administration (FDA) to market Vabysmo, a pioneering bispecific antibody for the treatment of neovascular or wet age-related macular degeneration (AMD) and diabetic macular edema (DME). This product is unique as it’s the first eye injection to target and suppress two disease-causing pathways, angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A), which are associated with vision-impairing retinal conditions. Clinical tests have demonstrated it to be as effective in improving vision as standard treatments, while maintaining a strong safety record. This FDA approval signifies a major advancement in retinal disease treatment, providing patients with the prospect of enhanced vision and a less burdensome treatment regimen.
How Are Different Regions Contributing to the Retinal Disorder Treatment Market’s Growth?
North America was the largest region in the retinal disorder treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the retinal disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Which Firms Are Setting the Benchmark in the Global Retinal Disorder Treatment Market?
Major companies operating in the retinal disorder treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Takeda Pharmaceutical Company Limited, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Genentech Inc., Santen Pharmaceutical Co. Ltd., Apellis Pharmaceuticals Inc., Kubota Pharmaceutical Holdings Co. Ltd, Alimera Sciences Inc., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Adverum Biotechnologies Inc., Kodiak Sciences Inc., Acucela Inc., IVERIC bio Inc., Oxurion NV, Graybug Vision Inc., Icon Bioscience Inc., Clearside Biomedical Inc., Aerpio Pharmaceuticals Inc., Neurotech Pharmaceuticals Inc., Ophthotech Corporation, Opthea Limited, PanOptica Inc., ThromboGenics NV
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=12701
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
